1 - Title Slide 2 - Faculty Disclosures 3 - Learning Objectives 4 - Prevalence of HF 5 - Diagnosis of HF 6 - Diagnosis of HF (Cont.) 7 - HFrEF Therapy 8 - Prognosis of HF 9 - Clinical Phenotypes 10 - Clinical Phenotypes (cont.) 11 - Take Home Messages I 12 - Sleep Disordered Breathing 13 - Prevalence of SDB, OSA and CSA 14 - Prevalence (Cont.) 15 - Prevalence (Cont.) 16 - Prognostic Impact 17 - Types of SDB in HFrEF 18 - Periodic Breathing 19 - Obstruktive or central Hypopnea? 20 - Apnea/Hypopnea? 21 - Normal vs Flattening 22 - Thoracoabdominal paradox 23 - Arousal Ventilation & Snoring 24 - Take Home Messages II 25 - Management of Sleep Apnea 26 - Definition, Discrimination, Diagnosis 27 - Central Breathing Disturbances 28 - Adaptive Servoventilation (ASV) 29 - ASV (Cont.) 30 - Heart Failure and SDB 31 - First Treatment of SDB 32 - Phenotypes of CSA 33 - Phenotypes Symptomatic vs. Oligosymptomatic 34 - Different Algorithms and Generations 35 - Quality of Life and Sleepiness 36 - Phenotypes Symptomatic vs. Oligo-/asymptomatic 37 - FACE Study 38 - First & New Generation 39 - Survival of patients 40 - Perspective 41 - Take Home Messages III 42 - Describe Results 43 - Effect of ASV 44 - Different Algorithms & Generations 45 - Summary ADVENT-HF Trial 46 - Primary Endpoint* 47 - Cumulative Incidence Mortality 48 - Effects of ASVPF 49 - Not Contraindicated 50 - ADVENT-HF Recommendation 51 - Differences AHF, CSA, SHF 52 - There is Debate 53 - Debate (Cont.) 54 - SERVE-HF & ADVENT-HF, CSA 55 - ADVENT-HF trial and SERVE-HF 56 - Specific QoL 57 - ASV and Sleepiness 58 - Take Home Messages IV 59 - Thank You